<VariationArchive RecordType="classified" VariationID="265785" VariationName="NM_183065.4(TMEM107):c.*608_*636dup" VariationType="Duplication" Accession="VCV000265785" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2016-10-14" MostRecentSubmission="2016-10-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="260475" VariationID="265785">
      <GeneList>
        <Gene Symbol="TMEM107" FullName="transmembrane protein 107" GeneID="84314" HGNC_ID="HGNC:28128" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="8172457" stop="8176380" display_start="8172457" display_stop="8176380" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="8076295" stop="8079713" display_start="8076295" display_stop="8079713" Strand="-" />
          </Location>
          <OMIM>616183</OMIM>
        </Gene>
        <Gene Symbol="SNORD118" FullName="small nucleolar RNA, C/D box 118" GeneID="727676" HGNC_ID="HGNC:32952" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="8173452" stop="8173588" display_start="8173452" display_stop="8173588" Strand="-" />
          </Location>
          <OMIM>616663</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_183065.4(TMEM107):c.*608_*636dup</Name>
      <CanonicalSPDI>NC_000017.11:8173566:AAGGATTATCCCACCTGACGATACAGACAAA:AAGGATTATCCCACCTGACGATACAGACAAAGGATTATCCCACCTGACGATACAGACAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="8173566" stop="8173567" display_start="8173566" display_stop="8173567" variantLength="29" positionVCF="8173566" referenceAlleleVCF="T" alternateAlleleVCF="TAAGGATTATCCCACCTGACGATACAGACA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="8076884" stop="8076885" display_start="8076884" display_stop="8076885" variantLength="29" positionVCF="8076884" referenceAlleleVCF="T" alternateAlleleVCF="TAAGGATTATCCCACCTGACGATACAGACA" />
      </Location>
      <OtherNameList>
        <Name>-7_22DUP</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.8076887_8076915dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.8076887_8076915dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.8173569_8173597dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.8173569_8173597dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_054916.1" sequenceAccession="NG_054916" sequenceVersion="1" change="g.7817_7845dup">
            <Expression>NG_054916.1:g.7817_7845dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_056674.1" sequenceAccession="NG_056674" sequenceVersion="1" change="g.4994_5022dup">
            <Expression>NG_056674.1:g.4994_5022dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351278.2" sequenceAccession="NM_001351278" sequenceVersion="2" change="c.*608_*636dup">
            <Expression>NM_001351278.2:c.*608_*636dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351279.2" sequenceAccession="NM_001351279" sequenceVersion="2" change="c.*608_*636dup">
            <Expression>NM_001351279.2:c.*608_*636dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351280.2" sequenceAccession="NM_001351280" sequenceVersion="2" change="c.*608_*636dup">
            <Expression>NM_001351280.2:c.*608_*636dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032354.5" sequenceAccession="NM_032354" sequenceVersion="5" change="c.*608_*636dup">
            <Expression>NM_032354.5:c.*608_*636dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_183065.4" sequenceAccession="NM_183065" sequenceVersion="4" change="c.*608_*636dup" MANESelect="true">
            <Expression>NM_183065.4:c.*608_*636dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_147092.2" sequenceAccession="NR_147092" sequenceVersion="2" change="n.859_887dup">
            <Expression>NR_147092.2:n.859_887dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1204" sequenceAccession="LRG_1204">
            <Expression>LRG_1204:g.4994_5022dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10588827" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="616663.0003" DB="OMIM" />
        <XRef Type="rs" ID="1555525654" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_183065.4(TMEM107):c.*608_*636dup AND Leukoencephalopathy with calcifications and cysts" Accession="RCV000256199" Version="1">
        <ClassifiedConditionList TraitSetID="32665">
          <ClassifiedCondition DB="MedGen" ID="C3281200">Leukoencephalopathy with calcifications and cysts</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-10-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-10-10" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-10-14" MostRecentSubmission="2016-10-14">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27571260</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="32665" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16872" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Leukoencephalopathy, brain calcifications, and cysts</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Leukoencephalopathy with calcifications and cysts</ElementValue>
                <XRef ID="MONDO:0013803" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LABRUNE SYNDROME</ElementValue>
                <XRef Type="MIM" ID="614561" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LCC</ElementValue>
                <XRef Type="MIM" ID="614561" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Leukoencephalopathy, brain calcifications, and cysts (LCC), also known as Labrune syndrome, is characterized by a constellation of features restricted to the central nervous system, including leukoencephalopathy, brain calcifications, and cysts, resulting in spasticity, dystonia, seizures, and cognitive decline (summary by Labrune et al., 1996).
See also cerebroretinal microangiopathy with calcifications and cysts (CRMCC; 612199), an autosomal recessive disorder caused by mutation in the CTC1 gene (613129) that shows phenotypic similarities to Labrune syndrome. CRMCC includes the neurologic findings of intracranial calcifications, leukodystrophy, and brain cysts, but also includes retinal vascular abnormalities and other systemic manifestations, such as osteopenia with poor bone healing, a high risk of gastrointestinal bleeding, hair, skin, and nail changes, and anemia and thrombocytopenia. Although Coats plus syndrome and Labrune syndrome were initially thought to be manifestations of the same disorder, namely CRMCC, molecular evidence has excluded mutations in the CTC1 gene in patients with Labrune syndrome, suggesting that the 2 disorders are not allelic (Anderson et al., 2012; Polvi et al., 2012).</Attribute>
                <XRef Type="MIM" ID="614561" DB="OMIM" />
              </AttributeSet>
              <XRef ID="542310" DB="Orphanet" />
              <XRef ID="C3281200" DB="MedGen" />
              <XRef ID="MONDO:0013803" DB="MONDO" />
              <XRef Type="MIM" ID="614561" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="619021" SubmissionDate="2016-10-10" DateLastUpdated="2016-10-14" DateCreated="2016-10-14">
        <ClinVarSubmissionID localKey="616663.0003_LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS" title="SNORD118, -7_22DUP_LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS" />
        <ClinVarAccession Accession="SCV000322751" DateUpdated="2016-10-14" DateCreated="2016-10-14" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-10-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 34-year-old man (family F343) with leukoencephalopathy, brain calcifications, and cysts (LCC; 614561), Jenkinson et al. (2016) identified compound heterozygous mutations in the SNORD118 gene: an n.-7_22dup (n.-7_22dup, NR_033294.1) affecting the promoter region, and ter5C-G (616663.0001). The duplication was not found in the ExAC database; functional studies of the duplication variant were not performed, and the parents were not available for segregation studies.</Attribute>
              <Citation>
                <ID Source="PubMed">27571260</ID>
              </Citation>
              <XRef DB="OMIM" ID="614561" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SNORD118" />
          </GeneList>
          <Name>SNORD118, -7_22DUP</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">-7_22DUP</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="616663.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="619021" TraitType="Disease" MappingType="Name" MappingValue="LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS" MappingRef="Preferred">
        <MedGen CUI="C3281200" Name="Leukoencephalopathy with calcifications and cysts" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

